NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
OCG
Oriental Culture Holding Ltd.
There isn't enough reported data to score OCG yet.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
OCG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
OCG's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
OCG PE Valuation
OCG has no meaningful PE right now: it lost money over the past year.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
OCG Forward outlook
There aren't enough analyst estimates for OCG to show an outlook.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over OCG in the latest year-over-year earnings comparison.
OCG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$107.26 | +$11.54 |
| Q4 2024 | -$118.80 | +$435.60 |
| Q4 2023 | -$554.40 | -212% |
OCG has swung to a loss: it lost $107.26 per share over the past year, after a profit the year before.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over OCG in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
OCG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $1.9M | +203% |
| Q4 2024 | $622.7K | -61% |
| Q4 2023 | $1.6M | -91% |
| Q4 2022 | $17.8M | -53% |
| Q4 2021 | $37.6M | +116% |
| Q4 2020 | $17.4M | +212% |
| Q4 2019 | $5.6M | +4.6% |
OCG's revenue has slid since its 2021 peak: $2M last quarter, down 95% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -203% | -232 points |
| Q4 2024 | -513% | -523 points |
| Q4 2023 | -274% | -322 points |
| Q4 2022 | 15% | -66 points |
| Q4 2021 | 29% | -21 points |
| Q4 2020 | 9.4% | N/A |
| Q4 2019 | 48% | N/A |
| Q2 2019 | 80% | N/A |
OCG's operating margin was −203% last quarter, down 232 points from the same quarter a year ago.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
OCG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$4.1M | -218% |
| Q4 2023 | $3.4M | +$5.4M |
| Q4 2022 | -$1.9M | -$1.3M |
| Q4 2021 | -$573.5K | -107% |
| Q4 2020 | $8.1M | +302% |
| Q4 2019 | $2M | -36% |
| Q2 2019 | $7.3M | +9184% |
| Q4 2018 | $3.1M | +7928% |
OCG's free cash flow has turned negative after years in the green: −$3M over the past year.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over OCG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
OCG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +79% | +15.9K shares |
| 1 year | +479% | +29.8K shares |
OCG has 35,968 diluted shares, up 479% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
| Q2 2019 | — |
| Q4 2018 | $125 |
| Q2 2018 | — |
| Q4 2017 | — |
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
OCG Net Leverage
OCG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
OCG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.6 | Oversold |
| Stochastic | 30.4 | Neutral |
OCG's weekly RSI is 25 (oversold) and its Stochastic is 30 (neutral).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
OCG PE vs Consumer Cyclical Sector
| Metric | OCG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
OCG has no meaningful PE right now: it lost money over the past year.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over OCG on trend strength, trading above more of its moving averages.
OCG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.63 | 0.6% below |
| 20 week MA | $1.64 | 1.2% below |
| 50 week MA | $46.0 | 96% below |
| 100 week MA | $1,165.0 | 100% below |
| 200 week MA | $1,218.6 | 100% below |
OCG is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over OCG on returns for 2026, with the stronger performance.
OCG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19,800.0 | $17,886.0 | -9.7% |
| 2021 | $17,886.0 | $16,632.0 | -7% |
| 2022 | $16,632.0 | $1,881.0 | -89% |
| 2023 | $1,881.0 | $943.8 | -50% |
| 2024 | $943.8 | $772.2 | -18% |
| 2025 | $772.2 | $56.8 | -93% |
| 2026 YTD | $56.8 | $1.62 | -97% |
OCG has finished every year since 2020 lower, and it's down 97% so far in 2026.